Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Bone Health

University of Alberta

$85,663.00

In Vivo microCT and microMRI Evaluation of Bone Marrow Lesion in a Rat Model of Osteoarthritis

EF 2010-11

Résumé
The current gold standard for diagnosing Osteoarthritis (OA) is radiographic evidence of joint space narrowing after cartilage damage, with accompanying changes in periarticular trabecular bone, and/or osteophyte formation at the joint margins to bone. However, often these diagnostic criteria are only identified in end-stage disease, leaving the patient with little to no treatment option other than pain relief. Beyond the changes observable with x-ray, OA may present pathophysiology which can be detected using physiological imaging modalities such as magnetic resonance imaging (MRI). One such phenomenon is bone marrow lesion (BML; historically termed bone marrow edema), which presents as a high-intensity, diffuse fluid signal within the epiphyses of the femur and tibia of many knee OA patients. Hence, the aim of our research is to devise an imaging approach to assess and detect MRI-based and Computed Tomography (CT)-based determinants of OA disease pathogenesis, prior to end-stage disease presentation. We plan to achieve this by conducting detailed sequential studies of multimodal imaging (microMRI and microCT) and histology in order to establish the cellular and/or physiological basis for BML, and in order to gauge the success of subsequent anti-inflammatory drug interventions. We will evaluate an established rat model of post-traumatic OA (secondary to the surgical disruption of knee ligaments and menisci) for evidence of BML and periarticular bone adaptations. In our hands, we have shown this model of knee OA will rapidly develop detectable BML, periarticular bone adaptation and eventual cartilage degradation. We believe the early detection of OA pathogenesis would be of great benefit in providing early treatment options that retard or even block further structural degradation of joint connective tissue structures and positively impact the bone health of the Canadian population.
Programme
Catalyst Grant: Bone Health
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
207820
Name
Doschak Michael R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Catalyst Grant: Bone Health
Projecttitle
In Vivo microCT and microMRI Evaluation of Bone Marrow Lesion in a Rat Model of Osteoarthritis
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$85,663
Cihrequipment2
$0
Programname2
Catalyst Grant: Bone Health
Keyworddelim
Anti-Inflammatory Drug Therapy; Antiresorptive Drug Therapy; Bone; Bone Marrow Lesion; Cartilage; Histology; Magnetic Resonance Imaging; Micro Computed Tomography; Multimodal Imaging; Osteoarthritis
Abstract
The current gold standard for diagnosing Osteoarthritis (OA) is radiographic evidence of joint space narrowing after cartilage damage, with accompanying changes in periarticular trabecular bone, and/or osteophyte formation at the joint margins to bone. However, often these diagnostic criteria are only identified in end-stage disease, leaving the patient with little to no treatment option other than pain relief. Beyond the changes observable with x-ray, OA may present pathophysiology which can be detected using physiological imaging modalities such as magnetic resonance imaging (MRI). One such phenomenon is bone marrow lesion (BML; historically termed bone marrow edema), which presents as a high-intensity, diffuse fluid signal within the epiphyses of the femur and tibia of many knee OA patients. Hence, the aim of our research is to devise an imaging approach to assess and detect MRI-based and Computed Tomography (CT)-based determinants of OA disease pathogenesis, prior to end-stage disease presentation. We plan to achieve this by conducting detailed sequential studies of multimodal imaging (microMRI and microCT) and histology in order to establish the cellular and/or physiological basis for BML, and in order to gauge the success of subsequent anti-inflammatory drug interventions. We will evaluate an established rat model of post-traumatic OA (secondary to the surgical disruption of knee ligaments and menisci) for evidence of BML and periarticular bone adaptations. In our hands, we have shown this model of knee OA will rapidly develop detectable BML, periarticular bone adaptation and eventual cartilage degradation. We believe the early detection of OA pathogenesis would be of great benefit in providing early treatment options that retard or even block further structural degradation of joint connective tissue structures and positively impact the bone health of the Canadian population.
Competitiondate
201006
Approvedterm2
1 yr 0 mth
Pinamesdelim
Doschak, Michael R
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $85,663~ $0~